Rick Anderson
Chairman, Founding Managing Director
Rick has nearly 35 years of senior executive leadership experience in the medical device industry.
Most recently, Rick served as Chairman of the Board and CEO of ConvaTec PLC, a FTSE 250 Company, where he had previously served as an Independent Director of the Board.
Prior to founding Revival, Rick served as a Managing Director at PTV Healthcare Capital. Prior to that Rick was Company Group Chairman, Johnson & Johnson, and Worldwide Franchise Chairman, Cordis Corporation. Rick also served as President of Cordis Corporation and was previously Worldwide Franchise Vice President of Centocor, Inc., which merged with Johnson & Johnson in 1999. Rick was part of the launch of the world’s first drug-eluting stent, the CYPHER® Sirolimus-eluting Coronary Stent. This breakthrough innovation for the treatment of restenosis (reblockage) has been used to treat more than three million patients worldwide. Before joining Johnson & Johnson, Rick served at Racal HealthCare, Inc., where he was Vice President, Global Marketing and prior to that, he spent a decade with Boehringer Mannheim Pharmaceuticals and Allergan Pharmaceuticals in various U.S. and global sales, sales management, and marketing management roles.
““If you would have told me two years ago that you raised $500 million all virtually, I would laugh. But it shows exactly that smart capital always finds a way.””
Rick holds a B.B.A. in Marketing from Mississippi State University. He served five years in the U.S. Army where he obtained the rank of captain. Rick was previously a member of the Accelerated Innovation Program Working Group for the National Heart Lung and Blood Institute (NHLBI). Rick serves as a Texas Health Catalyst Advisory Panel Member for The University of Texas Dell Medical School and previously as a Strategic Advisory Group Member for Nikon Corporation. Rick is also a member of the Economic Advisory Board of Mississippi State University, a consultant member of the Society for Cardiovascular Angiography and Interventions, and he has worked within the industry to shape global education of interventional specialties. He participates in the AdvaMed Venture Capital Advisory Council and the Dartmouth Device Development (3D) Symposium Executive Committee, and he is member of the Medical University of South Carolina President’s Advisory Group.
Rick currently serves on the boards of Augmedics, Distalmotion, and Kardion, Revival portfolio companies, in addition to Silk Road Medical. He also serves on the Executive Advisory Board of L.E.K. Consulting, a healthcare consulting firm. He previously served as an Independent Director at Apollo Endosurgery; as an Independent Director on ConvaTec PLC, a FTSE 250 company; a Director at Cardiologs prior to its acquisition by Phillips in January 2022; Chairman of the Board for Cardiva Medical; a Director for Intersect ENT before the company went public in July 2014; a Director at Corventis prior to its acquisition by Medtronic in June 2014; a Director at Cameron Health prior to its acquisition by Boston Scientific in June 2012; and Chairman of the Board for IDEV Technologies prior to its acquisition by Abbott in August 2013. He also previously served as a Director of Insite Vision and Chairman of the Board for Tryton Medical.